相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Current and future therapeutic approaches for osteosarcoma
Douglas J. Harrison et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2018)
Long non-coding RNA LUCAT1 modulates methotrexate resistance in osteosarcoma via miR-200c/ABCB1 axis
Zhe Han et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
Long non-coding RNA OIP5-AS1 functions as an oncogene in lung adenocarcinoma through targeting miR-448/Bcl-2
Jun Deng et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
CEP55 promotes the proliferation and invasion of tumour cells via the AKT signalling pathway in osteosarcoma
Leilei Xu et al.
CARCINOGENESIS (2018)
LncRNA OIP5-AS1 is overexpressed in undifferentiated oral tumors and integrated analysis identifies as a downstream effector of stemness-associated transcription factors
Ganesan Arunkumar et al.
SCIENTIFIC REPORTS (2018)
Anti-cancer activities of allyl isothiocyanate and its conjugated silicon quantum dots
Peng Liu et al.
SCIENTIFIC REPORTS (2018)
Osteosarcoma: Accelerating Progress Makes for a Hopeful Future
Amanda J. Saraf et al.
FRONTIERS IN ONCOLOGY (2018)
PSMC2 is up-regulated in osteosarcoma and regulates osteosarcoma cell proliferation, apoptosis and migration
Mingzhi Song et al.
ONCOTARGET (2017)
LncRNA OIP5-AS1 loss-induced microRNA-410 accumulation regulates cell proliferation and apoptosis by targeting KLF10 via activating PTEN/PI3K/AKT pathway in multiple myeloma
Nan Yang et al.
CELL DEATH & DISEASE (2017)
LncRNA FENDRR sensitizes doxorubicin-resistance of osteosarcoma cells through down-regulating ABCB1 and ABCC1
Zhu Kun-Peng et al.
ONCOTARGET (2017)
被撤回的出版物: LncRNA CCAT1 modulates the sensitivity of paclitaxel in nasopharynx cancers cells via miR-181a/CPEB2 axis (Retracted article. See vol. 22, pg. 144, 2023)
Qiaosu Wang et al.
CELL CYCLE (2017)
Antisense lncRNA FOXC2-AS1 promotes doxorubicin resistance in osteosarcoma by increasing the expression of FOXC2
Chun-Lin Zhang et al.
CANCER LETTERS (2017)
Clinico-pathological Study of Limb Salvage Surgery for Osteosarcoma: Experience in a Rural Cancer Center
Divya Vijayanarasimha et al.
INDIAN JOURNAL OF SURGICAL ONCOLOGY (2017)
Genomic signatures for paclitaxel and gemcitabine resistance in breast cancer derived by machine learning
Stephanie N. Dorman et al.
MOLECULAR ONCOLOGY (2016)
Fibronectin-targeted drug delivery in cancer
Heena Kumra et al.
ADVANCED DRUG DELIVERY REVIEWS (2016)
Silence of fibronectin 1 increases cisplatin sensitivity of non-small cell lung cancer cell line
Weiwei Gao et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)
Long non-coding RNA UCA1 promotes cisplatin/gemcitabine resistance through CREB modulating miR-196a-5p in bladder cancer cells
Jingjing Pan et al.
CANCER LETTERS (2016)
Matrix control of pancreatic cancer: New insights into fibronectin signaling
Mary Topalovski et al.
CANCER LETTERS (2016)
Long non-coding RNA LINC00161 sensitises osteosarcoma cells to cisplatin-induced apoptosis by regulating the miR-645-IFIT2 axis
Yuan Wang et al.
CANCER LETTERS (2016)
Targeting ABCB1 and ABCC1 with their Specific Inhibitor CBT-1® can Overcome Drug Resistance in Osteosarcoma
Marilu Fanelli et al.
CURRENT CANCER DRUG TARGETS (2016)
Identification of proteomic and metabolic signatures associated with chemoresistance of human epithelial ovarian cancer
Wenjuan Wu et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
Targeting ABCB1 (MDR1) in multi-drug resistant osteosarcoma cells using the CRISPR-Cas9 system to reverse drug resistance
Tang Liu et al.
ONCOTARGET (2016)
PI3K/Akt signaling in osteosarcoma
Jian Zhang et al.
CLINICA CHIMICA ACTA (2015)
Targeting autophagy to overcome drug resistance in cancer therapy
Ankit Kumar et al.
FUTURE MEDICINAL CHEMISTRY (2015)
The emerging role of IncRNAs in cancer
Maite Huarte
NATURE MEDICINE (2015)
Research progress on the multidrug resistance mechanisms of osteosarcoma chemotherapy and reversal
Suoyuan Li et al.
TUMOR BIOLOGY (2015)
LncRNA: A link between RNA and cancer
Guodong Yang et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2014)
Mechanism of Cancer Drug Resistance and the Involvement of Noncoding RNAs
Hongping Xia et al.
CURRENT MEDICINAL CHEMISTRY (2014)
miR-33a is up-regulated in chemoresistant osteosarcoma and promotes osteosarcoma cell resistance to cisplatin by down-regulating TWIST
Yong Zhou et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2014)
Functional interactions among microRNAs and long noncoding RNAs
Je-Hyun Yoon et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2014)
miR-382 inhibits tumor growth and enhance chemosensitivity in osteosarcoma
Meng Xu et al.
ONCOTARGET (2014)
Poised epigenetic states and acquired drug resistance in cancer
Robert Brown et al.
NATURE REVIEWS CANCER (2014)
The canonical Wnt-beta-catenin pathway in development and chemotherapy of osteosarcoma
Chengjun Li et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2013)
Posttranscriptional Gene Regulation by Long Noncoding RNA
Je-Hyun Yoon et al.
JOURNAL OF MOLECULAR BIOLOGY (2013)
Chemotherapy resistance in osteosarcoma: current challenges and future directions
Alexander J. Chou et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2006)
Molecular mechanisms of drug resistance
DB Longley et al.
JOURNAL OF PATHOLOGY (2005)
分享论文
